Experimental cancer drug study halted early
Disease control
Terminated
This study tested an experimental drug called SQ3370 in 53 people with advanced solid tumors that had stopped responding to other treatments. The main goal was to find a safe dose and check for side effects. The study was terminated early, so results are limited.
Phase: PHASE1, PHASE2 • Sponsor: Shasqi, Inc. • Aim: Disease control
Last updated May 08, 2026 12:03 UTC